Xponance, Inc. Cooper Companies, Inc. Transaction History

Xponance, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$306.88 - $380.0 $98,201 - $121,600	-320 Reduced 4.34%	7,053 $2.67 Million
Q3 2023 Oct 23, 2023	BUY	$315.92 - $397.36 $257,790 - $324,245	816 Added 12.44%	7,373 $2.34 Million
Q2 2023 Jul 13, 2023	SELL	$346.15 - $392.09 $35,307 - $39,993	-102 Reduced 1.53%	6,557 $2.51 Million
Q1 2023 Apr 17, 2023	BUY	$323.56 - $373.36 $25,561 - $29,495	79 Added 1.2%	6,659 $2.49 Million
Q4 2022 Jan 23, 2023	BUY	$248.67 - $334.17 $242,204 - $325,481	974 Added 17.37%	6,580 $0
Q3 2022 Oct 24, 2022	SELL	$263.81 - $337.27 $852,633 - $1.09 Million	-3,232 Reduced 36.57%	5,606 $1.48 Million
Q2 2022 Aug 02, 2022	BUY	$301.4 - $428.42 $1.62 Million - $2.3 Million	5,369 Added 154.77%	8,838 $2.77 Million
Q1 2022 Apr 20, 2022	BUY	$379.46 - $424.54 $86,896 - $97,219	229 Added 7.07%	3,469 $1.45 Million
Q4 2021 Jan 31, 2022	BUY	$373.53 - $434.12 $282,762 - $328,628	757 Added 30.49%	3,240 $1.36 Million
Q3 2021 Nov 05, 2021	SELL	$396.76 - $455.92 $96,809 - $111,244	-244 Reduced 8.95%	2,483 $1.03 Million
Q2 2021 Aug 12, 2021	BUY	$372.36 - $412.07 $15,639 - $17,306	42 Added 1.56%	2,727 $1.08 Million
Q1 2021 May 10, 2021	SELL	$357.26 - $392.57 $18,934 - $20,806	-53 Reduced 1.94%	2,685 $1.03 Million
Q4 2020 Feb 11, 2021	BUY	$319.05 - $363.32 $39,243 - $44,688	123 Added 4.7%	2,738 $995,000
Q3 2020 Oct 26, 2020	BUY	$280.08 - $347.78 $6,721 - $8,346	24 Added 0.93%	2,615 $882,000
Q2 2020 Aug 14, 2020	BUY	$270.93 - $320.3 $701,979 - $829,897	2,591 New	2,591 $735,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.